Scots and Nordic scientists set to explore sustainable skincare utilizing marine natural ingredients

Posted On: January 30, 2012

Scottish company Aquapharm has joined forces with Norwegian firm Aqua Bio Technology (ABT) to create a new generation of sustainable ingredients for the skincare market.

Together the companies hope to identify natural marine ingredients that could replace the petroleum-based components used extensively within the skincare market.

Scientists at Aquapharm believe marine microbes are the key to finding the bio-active ingredients of the future, and have developed specialist fermentation processes to source and produce such extracts.

Now they will undertake a development program in conjunction with ABT, sharing their expertise in a bid to prove these extracts can be produced with minimal environmental impact – and successfully commercialized for the personal care market.

More info

ArcticZymes establishes US subsidiary

Posted On: January 12, 2012

ArcticZymes AS announced today the formation of ArcticZymes Inc. a wholly owned subsidiary located in Plymouth Meeting, PA. ArcticZymes AS is a subsidiary of Biotec Pharmacon, focusing on enzymes for use in molecular biology and diagnostics.

“The formation of a U.S. based subsidiary is a key milestone for our company and our B2B and OEM customers in North America. Our intention is to facilitate our end users’ research by providing access to our products and technical support in an effective and productive manner,” said Jan Buch Andersen, Managing Director of ArcticZymes AS.

More info

 

Marine biotech in Norway continues to make waves

Posted On: December 6, 2011

Some 30 million NOK are to be made available for new initiatives alongside continuing support for established programmes such as MABIT and Marbank.

The Norwegian government acknowledged awareness of the importance of marine biotech to the economy by allocating dedicated funds within the new budget in October. Some 30 million NOK (3,84 million EUR) are to be made available for new initiatives alongside continuing support for established programmes such as MABIT and Marbank.

“We will have the first call for proposals from the new biotech program (BIOTEK2021) in February says special adviser Steinar Bergseth, who has long championed the sector.” Also I am pleased to say that internationally Norway is taking a lead in this area – perhaps only naturally considering our marine traditions and the length of our coastline.

 

Aqua Bio Technology Partners with Presperse Corporation in North America

Posted On: October 25, 2011

Presperse Corporation is pleased to announce that they have entered into a distribution agreement with Aqua Bio Technologies ASA (ABT) based in Norway. ABT develops and produces patented ingredients and technologies based on extensive research and development.

Their novel marine active ingredients are derived from the pure and protected environment of Northern waters. ABT’s flagship ingredient, Aquabeautine XL™, is a patented marine solution that adds moistureand improves the renewal of skin cells in an effective and gentle manner. The first self-limiting enzyme of its kind, it is also proven to deliver anti-aging effects in vivo. 100% natural,biodegradable and sustainable, Aquabeautine XL™ is targeted for use in anti-aging products, spa/cosmeceutical products, as well as products for sensitive skin.

More info

ABT signs distribution agreement with LICA Enterprises Group

Posted On: October 14, 2011

Aqua Bio Technology ASA (ABT) has entered into its third commercial distribution agreement in Asia for its flagship ingredient Aquabeautine XL™ (formerly known as Zonase X™) with Taiwanese company LICA Enterprises Group.

The agreement yields LICA Enterprises Group exclusivity on marketing and distribution of ABT’s products in Taiwan, China and Hong Kong.

This agreement allows ABT to complete its distribution network in the largest cosmetics markets globally. ABT’s strategy is to partner with leading distributors of cosmetic raw materials worldwide while maintaining its internal marketing focus. This yields ABT a greater degree of flexibility and strengthens the commercialization process of ABT’s patented ingredients in major target markets.

More info

 

Mar. Drugs, Volume 9, Issue 8 (August 2011), Pages 1307-1439: New Issue

Posted On: September 4, 2011

MDPI AG is pleased to announce the publication of the following issue:Mar. Drugs, Volume 9, Issue 8 (August 2011), Pages 1307-1439 at http://www.mdpi.com/1660-3397/9/8/

Table of Contents:

Shi-Yie Cheng, Pei-Wen Chen, Hwa-Pyng Chen, Shang-Kwei Wang and Chang-Yih Duh
Article: New Cembranolides from the Dongsha Atoll Soft Coral Lobophytum durum
Mar. Drugs 2011, 9(8), 1307-1318; doi:10.3390/md9081307
http://www.mdpi.com/1660-3397/9/81307/

Chia-Ying Kao, Jui-Hsin Su, Mei-Chin Lu, Tsong-Long Hwang, Wei-Hsien Wang, Jih-Jung Chen, Jyh-Horng Sheu, Yueh-Hsiung Kuo, Ching-Feng Weng, Lee-Shing Fang, Zhi-Hong Wen and Ping-Jyun Sung
Article: Lobocrassins A–E: New Cembrane-Type Diterpenoids from the Soft Coral Lobophytum crassum
Mar. Drugs 2011, 9(8), 1319-1331; doi:10.3390/md9081319
http://www.mdpi.com/1660-3397/9/81319/

Mariana Angelica Oliveira Bitencourt, Gracielle Rodrigues Dantas, Daysianne Pereira Lira, Jose Maria Barbosa-Filho, George Emmanuel Cavalcanti de Miranda, Barbara Viviana de Oliveira Santos and Janeusa Trindade Souto
Article: Aqueous and Methanolic Extracts of Caulerpa mexicana Suppress Cell Migration and Ear Edema Induced by Inflammatory Agents
Mar. Drugs 2011, 9(8), 1332-1345; doi:10.3390/md9081332
http://www.mdpi.com/1660-3397/9/81332/

Laura de Andrade Moura, Fredy Ortiz-Ramirez, Diana Negrao Cavalcanti, Suzi Meneses Ribeiro, Guilherme Muricy, Valeria Laneuville Teixeira and Andre Lopes Fuly
Article: Evaluation of Marine Brown Algae and Sponges from Brazil as Anticoagulant and Antiplatelet Products
Mar. Drugs 2011, 9(8), 1346-1358; doi:10.3390/md9081346
http://www.mdpi.com/1660-3397/9/81346/

Min-Kyoung Park, Uhee Jung and Changhyun Roh
Article: Fucoidan from Marine Brown Algae Inhibits Lipid Accumulation
Mar. Drugs 2011, 9(8), 1359-1367; doi:10.3390/md9081359
http://www.mdpi.com/1660-3397/9/81359/

Yi Wang, Jinkai Zheng, Peipei Liu, Wei Wang and Weiming Zhu
Communication: Three New Compounds from Aspergillus terreus PT06-2 Grown in a High Salt Medium
Mar. Drugs 2011, 9(8), 1368-1378; doi:10.3390/md9081368
http://www.mdpi.com/1660-3397/9/81368/

Ya-Nan Wang, Chang-Lun Shao, Cai-Juan Zheng, Yi-Yan Chen and Chang-Yun Wang
Article: Diversity and Antibacterial Activities of Fungi Derived from the Gorgonian Echinogorgia rebekka from the South China Sea
Mar. Drugs 2011, 9(8), 1379-1390; doi:10.3390/md9081379
http://www.mdpi.com/1660-3397/9/81379/

Anahit Penesyan, Jan Tebben, Matthew Lee, Torsten Thomas, Staffan Kjelleberg, Tilmann Harder and Suhelen Egan
Article: Identification of the Antibacterial Compound Produced by the Marine Epiphytic Bacterium Pseudovibrio sp. D323 and Related Sponge-Associated Bacteria
Mar. Drugs 2011, 9(8), 1391-1402; doi:10.3390/md9081391
http://www.mdpi.com/1660-3397/9/81391/

Cui Li, Ming-Ping La, Peng Sun, Tibor Kurtan, Attila Mandi, Hua Tang, Bao-Shu Liu, Yang-Hua Yi, Ling Li and Wen Zhang
Article: Bioactive (3Z,5E)-11,20-Epoxybriara-3,5-dien-7,18-olide Diterpenoids from the South China Sea Gorgonian Dichotella gemmacea
Mar. Drugs 2011, 9(8), 1403-1418; doi:10.3390/md9081403
http://www.mdpi.com/1660-3397/9/81403/

Takashi Maoka, Naoshige Akimoto, Miyuki Tsushima, Sadao Komemushi, Takuma Mezaki, Fumihito Iwase, Yoshimitsu Takahashi, Naomi Sameshima, Miho Mori and Yoshikazu Sakagami
Article: Carotenoids in Marine Invertebrates Living along the Kuroshio Current Coast
Mar. Drugs 2011, 9(8), 1419-1427; doi:10.3390/md9081419
http://www.mdpi.com/1660-3397/9/81419/

Sumei Li, Xinpeng Tian, Siwen Niu, Wenjun Zhang, Yuchan Chen, Haibo Zhang, Xianwen Yang, Weimin Zhang, Wenjun Li, Si Zhang, Jianhua Ju and Changsheng Zhang
Article: Pseudonocardians A–C, New Diazaanthraquinone Derivatives from a Deap-Sea Actinomycete Pseudonocardia sp. SCSIO 01299
Mar. Drugs 2011, 9(8), 1428-1439; doi:10.3390/md9081428
http://www.mdpi.com/1660-3397/9/81428/

More info

Fish enzymes show potential to boost dairy flavors: Study

Posted On: June 14, 2011

Enzymes from salmon and hoki may enhance the flavor profile of dairy products, like specialty cheeses, suggests a study from Canada and New Zealand.

Digestive enzymes are used to speed up the ripening of dairy products such as cheeses, and play an important role in the development of the finished products flavor. Many such enzymes – called pregastric esterase (PGE) or pregastric lipase – are obtained from ruminants, like calves or lambs.

According to new data published in Food Chemistry, digestive enzymes from fish such as salmon and hoki may also be used to produce desirable flavor profiles in dairy products.

The enzymes from these fish may also offer technological benefits, by being able to function at considerably lower temperatures than enzymes obtained from other fish or mammals, explained researchers from McGill University and The New Zealand Institute for Plant and Food Research Limited.

Such a characteristic, suggested the researchers, “could make the enzymes suitable for applications such as the hydrolysis of milk fat, release of FAs and flavor volatiles, desired in specialty cheeses and other ‘ripened’ dairy products”.

More info

Enzymicals AG and the Institute of Marine Biotechnology e.V. establish cooperation

Posted On: June 14, 2011

Enzymicals AG, an emerging company in the field of industrial (white) biotechnology, and the Institute of Marine Biotechnology e.V. (IMaB), an association in the area of marine (blue) biotechnology, have signed a comprehensive agreement to cooperate in the future. The two institutions, both located in Greifswald, Germany, combine their competencies in the commercialization of alternative expression systems and functional genome analysisfor the production of fine chemicals. The signed contract includes the joint use of innovative technologies for the identification and production of novel enzymes from aquatic sources, among others. Dormant potentials of marine habitats for biotransformations can be deciphered and brought into market by the focused application of proteomics-based biotechnology, says Prof. Dr. Thomas Schweder of the IMaB. Together with Enzymicals AG, we can offer our expertise in the field of de novo genome sequencing and gene annotation to a wide audience as a service.

More info

NineSigma Seeks Natural Compound Collections for Screening: invites proposals for the purchase of natural compound collections

Posted On: February 21, 2011

NineSigma reports that they are looking for proposals for the purchase of natural compound collections for screening. The compounds may be pure or extracts (fractionated or not) or semi-synthetic but must be derived from sustainable natural sources. They are interested in compound collection acquisition, licensing, supplier agreement. Co-development of any discovered activities is also possible.

Description

Collection(s) will be screened in assays relevant to the development of consumer care products. As such, compounds should be potentially suitable for such applications and must either be currently available or have a reasonable likelihood of being available on sustainable commercial scales (tons).

Possible approaches:
- Samples may be pure or semi-pure, including extracts (preferably fractionated).
- Among others, libraries of commodity natural products, natural product components, and consumer care ingredients are all possible sample sources.
- Developing nations with unique biota that could be sustainably developed may present with interesting avenues of investigation.
- Low, medium, and/or high molecular weight compounds are all of interest provided they are derived from acceptable natural sources.

Approaches not of interest:
- Synthetic chemical libraries
- Collections of pharmaceutical drugs
- Compounds derived from animal sources unless they are obtained “without harm”
- Biological agents
- Compounds or extracts that cannot be supplied (or potentially supplied) on sustainable commercial scales.

More info

Publication: Marine-derived functional ingredients as potential antioxidants in the food industry–An overview

Posted On: February 17, 2011

Dai-Hung Ngo, Isuru Wijesekara, Thanh-Sang Vo, Quang Van Ta and Se-Kwon Kim

Abstract

Recently, a great deal of interest has been developed by the consumers towards natural bioactive compounds as functional ingredients in the food products due to their various health beneficial effects. Hence, it can be suggested that antioxidative functional ingredients from marine foods and their by-products are alternative sources for synthetic ingredients that can contribute to a consumer’s well-being, as a part of nutraceuticals and functional foods. This contribution presents an overview of the marine food-derived antioxidants such as bioactive peptides, chitooligosaccharide derivatives, sulfated polysaccharides, phlorotannins and carotenoids with the potential utilization in the food industry.

More info

 
Follow Me on Twitter